Andy Merken and Shawn Foley are speaking at the Redefining Early Stage Investments (RESI) Conference, held virtually March 14th-16th, 2023.
Don’t miss Shawn Foley‘s presentation, “IP Considerations for Startups – Navigating to Success”.
“Intellectual Property is an absolutely key issue for life science startups to understand in order to make the right decisions along the journey toward commercialization. This session, led by Burns & Levinson Partner Shawn Foley, will address the main aspects of a good IP strategy that will help guide life science entrepreneurs be better prepared as they move their technologies forward.”
Later, join Andy Merken as he moderates the Early Stage Therapeutics panel, “Bringing the Newest Therapies to the Clinic”.
“This panel aims to bring a diverse group of experts & senior decision making staff from VCs, corporate pharma, and other investor types who focus on biotech/therapeutics investments together to discuss topics such as:
- The decision-making process
- Current areas of interest and areas of high need
- How companies can better differentiate themselves, especially those in overcrowded indications
- Common mistakes/red flags
- Recently successful deals and how they were successful
The moderator will guide the discussion through topics including how the investors source & vet novel therapeutic assets, what kinds of technology are of interest to them right now, and how they as investors work with a startup to move a new drug toward commercialization.“
Click here to register and to learn more.
Andy Merken co-chairs Burns & Levinson’s Life Sciences group and Securities group. Shawn Foley is a partner in the firm’s Patent, Intellectual Property, and IP Litigation groups.
receive news & alerts
Yes! I’d like to receive updates with firm news and insights that are relevant to me!